BEAT logo

HeartBeam, Inc. Stock Price

NasdaqCM:BEAT Community·US$84.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

BEAT Share Price Performance

US$2.44
0.28 (12.96%)
US$2.44
0.28 (12.96%)
Price US$2.44

BEAT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with mediocre balance sheet.

7 Risks
1 Reward

HeartBeam, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$20.6m

Other Expenses

-US$20.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.60
0%
0%
0%
View Full Analysis

About BEAT

Founded
2015
Employees
16
CEO
Robert Eno
WebsiteView website
www.heartbeam.com

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

Recent BEAT News & Updates

Recent updates

No updates